Tocilizumab for the Treatment of Mevalonate Kinase Deficiency

Mevalonate kinase deficiency (MKD) is a severe autoinflammatory disease caused by recessive mutations in MVK resulting in reduced function of the enzyme mevalonate kinase, involved in the cholesterol/isoprenoid pathway. MKD presents with periodic episodes of severe systemic inflammation, poor qualit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafiq, Nadia K., Lachmann, Helen, Joensen, Frodi, Herlin, Troels, Brogan, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129367/
https://www.ncbi.nlm.nih.gov/pubmed/30225156
http://dx.doi.org/10.1155/2018/3514645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129367/
https://www.ncbi.nlm.nih.gov/pubmed/30225156
http://dx.doi.org/10.1155/2018/3514645

Ejemplares similares